West Pharmaceutical Services (WST) reported quarterly earnings results on Thursday, Apr-28-2016. The company said it had a profit of $0.53 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $0.51. The company posted revenue of $362.10 million in the period, compared to analysts expectations of $356.32 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.
Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Initiated by Wells Fargo to “Outperform” on Mar 22, 2016.
West Pharmaceutical Services opened for trading at $72.15 and hit $72.49 on the upside on Wednesday, eventually ending the session at $72.1, with a gain of 0.21% or 0.15 points. The heightened volatility saw the trading volume jump to 4,65,165 shares. Company has a market cap of $5,215 M.
In a different news, on Mar 2, 2016, Michael A Anderson (Vice President & Treasurer) sold 16,414 shares at $63.60 per share price. According to the SEC, on Mar 1, 2016, Thomas W Hofmann (director) sold 3,042 shares at $62.70 per share price. On Feb 26, 2016, Heino Lennartz (President Europe) sold 5,680 shares at $62.46 per share price, according to the Form-4 filing with the securities and exchange commission.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).